Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Gentest Corporation
Profile last edited on: 3/3/15      CAGE: 1RLX7      UEI: JEN5BQJR2Y18

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1982
First Award
1985
Latest Award
1998
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

6 Henshaw Street
Woburn, MA 01801
   (781) 935-5115
   N/A
   www.gentest.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Gentest Corporation provides genetic toxicological testing services. The company studies the effects of poisons as well as their methods of treatment. This company manufactures the systems used during testing. On December 20, 2000, Gentest Corp was purchased by health care supplies company Becton, Dickinson and Co. (NYSE: BDX) of Franklin Lakes, N.J. The firm now operates as BD Gentest.

Extent of SBIR involvement

User Avatar
Phase I Awards
13
Phase II Awards
10
Conversion Rate
76.92%
Phase I Dollars
$895,953
Phase II Dollars
$4,601,115
Total Awarded
$5,497,068

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1998 2 NIH $581,345
Project Title: Development of Caco-2 Cells Expressing Cytochromes P450
1998 2 NIH $555,626
Project Title: Overexpression of Xenobiodc Metabolizing Enzymes
1998 1 NIH $100,000
Project Title: In Vitro Systems To Study Biliary Transport
1997 2 NIH $885,000
Project Title: Mammalian Cells Expressing FMO
1995 2 NIH $425,174
Project Title: Development of cell lines expressing rat cytochrome

Key People / Management

  Charles L Crespi -- President

  Vaughn Miller

  Bruce W Penman

Company News

There are no news available.